Radiation exposure of adrenal vein sampling: a German Multicenter Study

Objective Adrenal vein sampling (AVS) represents the current diagnostic standard for subtype differentiation in primary aldosteronism (PA). However, AVS has its drawbacks. It is invasive, expensive, requires an experienced interventional radiologist and comes with radiation exposure. However, exact radiation exposure of patients undergoing AVS has never been examined. Design and methods We retrospectively analyzed radiation exposure of 656 AVS performed between 1999 and 2017 at four university hospitals. The primary outcomes were dose area product (DAP) and fluoroscopy time (FT). Consecutively the effective dose (ED) was approximately calculated. Results Median DAP was found to be 32.5 Gy*cm2 (0.3–3181) and FT 18 min (0.3–184). The calculated ED was 6.4 mSv (0.1–636). Remarkably, values between participating centers highly varied: Median DAP ranged from 16 to 147 Gy*cm2, FT from 16 to 27 min, and ED from 3.2 to 29 mSv. As main reason for this variation, differences regarding AVS protocols between centers could be identified, such as number of sampling locations, frames per second and the use of digital subtraction angiographies. Conclusion This first systematic assessment of radiation exposure in AVS not only shows fairly high values for patients, but also states notable differences among the centers. Thus, we not only recommend taking into account the risk of radiation exposure, when referring patients to undergo AVS, but also to establish improved standard operating procedures to prevent unnecessary radiation exposure.

[1]  P. Glendenning,et al.  Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement , 2018, Annals of clinical biochemistry.

[2]  L. Sechi,et al.  The SPARTACUS Trial: Controversies and Unresolved Issues , 2017, Hormone and Metabolic Research.

[3]  W. Young,et al.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.

[4]  W. Spiering,et al.  Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. , 2016, The lancet. Diabetes & endocrinology.

[5]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[6]  H. Wallaschofski,et al.  Prevalence of Malignancies in Patients With Primary Aldosteronism. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  F. Beuschlein,et al.  Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. , 2015, European journal of endocrinology.

[8]  P. Plouin,et al.  Influence of Diagnostic Criteria on the Interpretation of Adrenal Vein Sampling , 2015, Hypertension.

[9]  Gian Paolo Rossi,et al.  An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism , 2014, Hypertension.

[10]  S. Trerotola,et al.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  M. Stowasser.  Primary aldosteronism in 2011: Towards a better understanding of causation and consequences , 2012, Nature Reviews Endocrinology.

[12]  J H Hendry,et al.  ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context , 2012, Annals of the ICRP.

[13]  F. Beuschlein,et al.  Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. , 2011, European journal of endocrinology.

[14]  F. Beuschlein,et al.  Adrenal Venous Sampling: Evaluation of the German Conn's Registry , 2011, Hypertension.

[15]  B. Allolio,et al.  Adrenal vein sampling for Primary Aldosteronism: time for a reality check , 2010, Clinical endocrinology.

[16]  Gabriel Bartal,et al.  Occupational Radiation Protection in Interventional Radiology: A Joint Guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology , 2009, CardioVascular and Interventional Radiology.

[17]  T. Yoshizumi,et al.  Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007. , 2009, Radiology.

[18]  L. S. Schultze Kool,et al.  Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism , 2009, Annals of Internal Medicine.

[19]  Gabriel Bartal,et al.  Guidelines for patient radiation dose management. , 2009, Journal of vascular and interventional radiology : JVIR.

[20]  F. Beuschlein,et al.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. , 2009, The Journal of clinical endocrinology and metabolism.

[21]  W. Huda,et al.  Effective doses in radiology and diagnostic nuclear medicine: a catalog. , 2008, Radiology.

[22]  J. Ector,et al.  Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[23]  E. Porteri,et al.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.

[24]  W. Young,et al.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  J. Funder,et al.  Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the Argument. , 2018, Hypertension.

[26]  J. Lenders,et al.  Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Con Side of the Argument , 2018, Hypertension.

[27]  Morris J. Brown,et al.  Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. , 2012, The Journal of clinical endocrinology and metabolism.

[28]  Managing patient dose in computed tomography. A report of the International Commission on Radiological Protection. , 2000, Annals of the ICRP.

[29]  J C Le Heron,et al.  Estimation of effective dose to the patient during medical x-ray examinations from measurements of the dose-area product. , 1992, Physics in medicine and biology.

[30]  Saskia,et al.  Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma , 2022 .